October 06, 2026 at 11:32 AM UTC
Kairos Pharma, LTD. reports additional corporate update
Kairos Pharma, LTD. filed an 8-K covering other material corporate events. Nelo verified the filing topics against the primary SEC document. This is a company disclosure filed with the SEC, not an SEC enforcement action.
Official source: U.S. Securities and Exchange Commission
Official source published: October 06, 2026 at 11:30 AM UTC
Open official source